US Government Keeps Lights On But Pharma Priorities For PBM Reform, Rare Diseases Nixed

 
• By Sarah Karlin-Smith
  
US Capitol at sunset.
Congress narrowly avoided a government shutdown, but pharma priorities were cut from the bill. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Legislation

More from Rare Diseases